Skip to main content
. Author manuscript; available in PMC: 2010 Mar 2.
Published in final edited form as: Neurology. 2005 Jul 12;65(1):159–162. doi: 10.1212/01.wnl.0000167545.38161.48

Table 3. Multivariate odds of past or current acetylcholinesterase inhibitor use among the 2,546 patients with Alzheimer disease*.

Characteristic Odds ratio 95% CI
African American 0.6 0.4–0.9
Latino 0.9 0.7–1.1
Asian 0.7 0.5–1.0
Other 0.5 0.3–0.9
White 1.0 (ref)
Age per 5 y 0.9 0.8–0.9
Education per 5 y 1.1 1.0–1.3
Female 0.9 0.7–1.1
Lives alone 0.8 0.6–1.1
Lives in a household 0.8 0.6–1.0
Lives in a health facility/group setting 1.00 0.7–1.4
Lives with Spouse 1.0 (ref)
Spouse caregiver 1.4 1.0–1.8
Child/other caregiver 1.0 (ref)
Medicare part A or B 1.4 1.1–1.8
MediCal 0.6 0.4–0.8
Other health insurance 1.3 1.1–1.6
No health insurance 0.5 0.3–1.0
Hypertension 1.3 1.1–1.5
Diabetes 1.0 0.8–1.4
MMSE score
 <12 1.4 1.1–1.8
 12–19 1.2 1.0–1.5
 >19 1.0 (ref)
BRDRS score
 >5.5 1.7 1.3–2.3
 2.5–5.5 1.2 1.0–1.6
 <2.5 1.0 (ref)
*

Data on covariates missing for 27 patients.

MMSE = Mini-Mental State Examination; BRDRS = Blessed-Roth Dementia Rating Scale.